Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Uterine Myoma With 2.5 or 5 mg Mifepristone Daily During 3 Months With 9 Months Post-treatment Follow-up. Randomized Clinical Trial.

NCT01786226 is registered in ClinicalTrials.gov with Mediterranea Medica S. L. as lead sponsor.

NCT NCT01786226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01786226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Uterine Myoma With 2.5 or 5 mg Mifepristone Daily During 3 Months With 9 Months Post-treatment Follow-up. Randomized Clinical Trial.
Lead sponsor
Mediterranea Medica S. L.
Phase
Phase 2/3
Overall status
Terminated
Start date
March 31, 2010
Completion date
March 31, 2012
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids